Interestingly, B cells have been reported to be part of the GBM immune landscape, characterized by an immunosuppressive activity toward activated CD8+ T cells, through overexpression of inhibitory molecules such as PD-L1 and CD155, and production of the immunosuppressive cytokines TGFβ and IL10.46 This evidence concerns the gene TGFB1 and glioblastoma.